Oxford University Innovation spins out LiliumX

2021-05-18

Oxford University Innovation and LiliumX have completed the technology transfer process, establishing LiliumX as a University of Oxford spin-out. LiliumX is spun out from the Department of Biochemistry, and it is the first company in 24 years to be formed solely from this Department. As part of the spin-out process, LiliumX is licensing world-class protein conjugation technologies from Oxford University Innovation, including the SpyTag/SpyCatcher system. LiliumX is proud to be a part of the University's high-profile portfolio, and LiliumX's founders thank the Department of Biochemistry and Oxford University Innovation for their support and fruitful collaboration. Oxford University Innovation's spin-out portfolio can be found here.

More Updates

More Updates

Contact Us

United States

Valink Therapeutics Inc
50 Milk Street,
16th floor,
Boston,
MA 02109

United Kingdom

Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ

a tick

Message sent successfully.

a cross

Oops, something happened. Please try again.

United Kingdom

Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ
United States

Valink Therapeutics Inc
50 Milk St.,
16th floor,
Boston,
MA 02109